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Abstract
Background
Mammographic density (MD) is one of the strongest breast cancer risk factors. Its age-
related characteristics have been studied in women in western countries, but whether these
associations apply to women worldwide is not known.
Methods and findings
We examined cross-sectional differences in MD by age and menopausal status in over
11,000 breast-cancer-free women aged 35–85 years, from 40 ethnicity- and location-spe-
cific population groups across 22 countries in the International Consortium on Mammo-
graphic Density (ICMD). MD was read centrally using a quantitative method (Cumulus) and
its square-root metrics were analysed using meta-analysis of group-level estimates and lin-
ear regression models of pooled data, adjusted for body mass index, reproductive factors,
mammogram view, image type, and reader. In all, 4,534 women were premenopausal, and
6,481 postmenopausal, at the time of mammography. A large age-adjusted difference in
percent MD (PD) between post- and premenopausal women was apparent (–0.46 cm [95%
CI: −0.53, −0.39]) and appeared greater in women with lower breast cancer risk profiles; var-
iation across population groups due to heterogeneity (I2) was 16.5%. Among premeno-
pausal women, thepPD difference per 10-year increase in age was −0.24 cm (95% CI:
−0.34, −0.14; I2 = 30%), reflecting a compositional change (lower dense area and higher
non-dense area, with no difference in breast area). In postmenopausal women, the corre-
sponding difference inpPD (−0.38 cm [95% CI: −0.44, −0.33]; I2 = 30%) was additionally
driven by increasing breast area. The study is limited by different mammography systems
and its cross-sectional rather than longitudinal nature.
Conclusions
Declines in MD with increasing age are present premenopausally, continue postmenopaus-
ally, and are most pronounced over the menopausal transition. These effects were highly
consistent across diverse groups of women worldwide, suggesting that they result from an
intrinsic biological, likely hormonal, mechanism common to women. If cumulative breast
density is a key determinant of breast cancer risk, younger ages may be the more critical
periods for lifestyle modifications aimed at breast density and breast cancer risk reduction.
International study of mammographic density and ageing
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Author summary
Why was this study done?
• Breast density, a measure of the amount of dense to fatty tissue in the breast, is a strong
marker of breast cancer risk.
• Breast density determinants have been studied in high-income countries, but not in
women worldwide.
What did the researchers do and find?
• We studied how breast density differed by age and menopausal status in diverse groups
of women from 22 countries worldwide.
• For over 11,000 women, mammograms were read centrally and risk factor data
harmonised.
• We found that, regardless of the country and ethnic group of women, breast density was
much lower in postmenopausal than in premenopausal women of the same age.
• Additionally, as a relative proportion of breast area, breast density was lower in older
women both among premenopausal and postmenopausal women. Among premeno-
pausal women, breast density changed with age without an increase in breast area, but
among postmenopausal women, the latter also increased.
What do these findings mean?
• That this change in breast density with age is seen internationally suggests that the
change is due to a universal biological mechanism inherent to all women.
• If cumulative breast density is a key determinant of breast cancer risk, younger ages
may be the more critical periods for lifestyle modifications aimed at breast density and
breast cancer risk reduction.
Introduction
Mammographic density (MD), a measure of the amount of radiopaque fibroglandular as
opposed to fat tissue in the breast, is amongst the strongest of breast cancer risk factors [1–3].
Parallels have been drawn between life-course trajectories of MD and Pike’s model for the rate
of breast tissue ageing [1–4]. The latter model hypothesizes that Clemmesen’s hook (the slow-
ing of the rate of increase of age-specific breast cancer incidence rates after menopause, S1 Fig)
is due to a reduction in the rate of breast tissue ageing in postmenopausal women [4–6]. MD
also declines during the menopausal transition and with ageing; thus, MD may be a tissue-spe-
cific marker of the biological processes underlying the rate of breast tissue ageing and, ulti-
mately, the shape of the breast cancer incidence–age curve [2,7,8]. The nature and drivers of
the cumulative MD profile thus become of interest to inform which periods in life MD reduc-
tions may be best targeted to.
International study of mammographic density and ageing
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MD associations with ageing have been examined in longitudinal studies [8–12] and
inferred from cross-sectional studies [13–15]. Many found non-linear declines with increasing
age [8,10–12], often steepest during the perimenopausal period, and some suggested that MD
plateaus by age 65 years [11,12]. The majority of these studies were conducted at screening
ages (predominantly 50–70 years) and in countries with high breast cancer incidence rates.
However, whilst Clemmesen’s hook has been observed in countries spanning the range of
breast cancer incidence rates (as shown for selected international populations in S1 Fig), it is
not known how MD changes with age in women from countries beyond westernised popula-
tions. Studying whether the MD–age association holds internationally will shed light on
whether the association is likely to be driven by an intrinsic biology or is a consequence of, or
specific to, westernised lifestyles.
The International Consortium on Mammographic Density (ICMD) is an international
pooling consortium of cross-sectional individual-level epidemiologic and MD data on over
11,000 breast-cancer-free women from 22 diverse countries. In this consortium, we examined
differences in MD by menopausal status and age across 4 decades of life.
Methods
Ethics approvals for ICMD were obtained from the International Agency for Research on Can-
cer (IEC 12–34). Each individual participating study had received local ethical approval at the
time of the original conduct of the study and again to contribute to the consortium.
The ICMD methodology and contributing studies are discussed in detail elsewhere [16]. In
brief, the consortium pooled individual-level epidemiologic and MD data on 11,755 women
without breast cancer from 27 studies (listed in S1 Text) in 22 countries that span low to high
breast cancer incidence rates. To enhance heterogeneity, 7 studies contributed multiple ethnic
groups, e.g., Chinese, Malay, and Indian women in both Singapore and Malaysia, totalling 40
ethnicity- and location-specific ‘population groups’. From each population group, we sought
to include a random selection of 200 pre- and 200 postmenopausal women aged 35 years or
older at the time of mammography. These sample sizes were based on calculations to allow,
within each population group and menopause stratum, estimation of mean percent MD (PD)
within 1% at a 95% confidence level, assuming a stratum-specific standard deviation (SD) of
7% (for which n = 180). An additional 10% (rounded to n = 20) was added to account for
potential later exclusions (e.g., missing data, poor image quality). Population groups were cate-
gorised into broad ethnic groups as follows: (i) East Asian (Japanese, Korean, and Chinese),
(ii) mestizo (Mexican and Chilean) and Hawaiian, (iii) South Asian (Indian and Malay), (iv)
white (European and of European descent), (v) Eastern Mediterranean (Iranian, Turkish,
Egyptian, Israeli Arab, and Israeli Jewish) and (vi) black (Kenyan, black South African, and
black women in the UK and US). Mammograms were originally taken as part of organised
screening (n = 13 studies), opportunistic or community-based screening (n = 8), mammogra-
phy trials (n = 3), or research (n = 3). We also extracted the best estimate of the age-standard-
ised incidence rate (ASR per 100,000) for breast cancer from Cancer Incidence in Five
Continents, GLOBOCAN, or used another estimate [17,18] for each population group. From
these ASR estimates, population groups were categorised as originating from a source popula-
tion with low (ASR < 50), medium (ASR 50–69), or high (ASR 70) breast cancer incidence
rate.
ICMD harmonised data from each study on sociodemographic and lifestyle factors, includ-
ing height and weight to calculate body mass index (BMI, in kg/m2), ideally obtained at the
time of mammography. For menopausal status, study-specific definitions were used, as pro-
vided in S1 Table. In brief, postmenopausal at the time of mammography was defined as no
International study of mammographic density and ageing
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longer having menstrual periods (n = 7 studies) or no periods for the past 6 or 12 months
(n = 15), self-reported postmenopausal (n = 3), or a combination of age, menstruation, hor-
mone replacement therapy (HRT), and hysterectomy/oophorectomy history (n = 2). Perimen-
opausal women were excluded from ICMD sample selection in 10 studies, were not defined
separately in 13 studies, and were included and categorised separately in 4 studies (2.7% of all
women). For consistency, the latter were reclassified as premenopausal for analyses. Meno-
pausal variables were ascertained at or after mammography for 22 studies. For 4 of the remain-
ing studies, menopausal status was assumed not to have changed as it was ascertained less than
1 year before mammography, on average. For 1 study, in which risk factors were ascertained
via questionnaire an average of 2.8 years before mammography, a premenopausal woman at
the time of the questionnaire was considered postmenopausal at the time of mammography if
her age at mammography exceeded the study’s mean age at menopause.
In ICMD, MD was read centrally in Cumulus [19] on digitised film-screen, raw digital, or
processed digital images, by 1 of 3 experienced readers (VM, IdSS, NB). For each woman, 1
image (craniocaudal or mediolateral oblique view) was read. Images were randomly allocated
to batches, and batches were randomly allocated to readers, as previously described [16]. Read-
ings included 3% within-reader, within-batch repeats and 5% between-reader repeats. MD
measures obtained were dense area, non-dense area, and breast area (dense area + non-dense
area), all in square centimetres, and PD (PD = 100 × dense area/breast area). PD and dense
and non-dense areas that were read on processed images were first corrected to a raw-image
equivalent using published equations [20].
After excluding poor-quality images and suspected tumours (n = 288), women with no
BMI data (n = 2) or with extreme BMIs (>3.8 SD from her population group mean, n = 42),
11,423 women were included, 11,232 of whom had PD data, 11,375 dense-area readings, and
11,184 non-dense-area and breast-area readings. Differences in the numbers of women with
different MD metrics arose because, in some mammograms, dense area could be estimated
but the breast edge was not visible (thus PD, non-dense area, and breast area were missing),
and, for 78 images from 1 study, PD could be estimated, but uncertainties in the original pixel
size prevented the calculation of absolute areas.
Statistical methods
We analysed PD and dense, non-dense, and breast area after square-root transforming each
measure to improve normality of residuals. The use of the square-root transformation of MD
in regression models means that absolute differences in areas are smaller at the lower end of
the PD range. For example, an increase in
p
PD from 4 to 5 (change in
p
PD of 1) is, on the
original scale, an increase from 42 to 52, or an absolute increase of 9 (from 16 to 25), but the
same change in
p
PD of 1 from 7 to 8 is, on the original scale, an increase from 72 to 82, or an
absolute increase of 15 (from 49 to 64). To aid the interpretation on the square-root scale,
p
MD can be interpreted by considering areas as squares, thus regression model beta-coeffi-
cients represent differences in the width, in centimetres, of the side of the square. Similarly, as
PD (percent) is the dense area per 100 cm2,
p
PD is the width of a dense square within a 10
cm × 10 cm square, and therefore beta-coefficients for
p
PD represent differences in the dense
square width, within a 10 cm × 10 cm square.
We examined cross-sectional differences in
p
MD measures by age and menopausal status
using 2 approaches. First, we examined associations by population group and combined esti-
mates using a random effects meta-analysis. Population group estimates were obtained from a
multi-level linear regression model to account for repeat MD readings between readers and
between batches for the same woman. The percentage of variation in regression estimates
International study of mammographic density and ageing
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across population groups that was due to heterogeneity was examined using the I2 statistic
[21], for which percentages of 0%,<30%, 30%–60%, and>60% were roughly considered as
no, low, moderate, and large heterogeneity, respectively. Second, we pooled all ICMD data and
analysed them in a single model by extending the multi-level model to a third level to account
for within-population-group correlations. For both approaches, explanatory variables included
fixed effects for the 2 primary variables of interest, age (linear) and menopausal status (binary),
as well as BMI (linear + quadratic), ever use of HRT (coded as never, past, current, ever [some
studies did not distinguish past and current use], or unknown), parity (continuous), age at
first birth (categorical: <20, 20 to<25, 25 to<30,30 years), and reader (categorical). All
analyses were based on participants with non-missing data for all variables, as completeness
was high (>99%), as per eligibility for inclusion. For pooled analyses (the second approach),
factors with between-study variation were additionally adjusted for, i.e., mammogram view
and image type. The pooled analysis was also used to examine associations with age in 5-year
bands, and linear associations with age were compared to the best-fitting fractional polynomial
models.
Interactions of age and menopausal status with demographic and lifestyle factors were
tested using likelihood ratio tests. We also examined effect modification by ‘breast area for
BMI’, a proxy for a woman’s breast size independent of her BMI, which we generated as the
residual of the regression of
p
breast area on BMI (linear and quadratic terms) and mammog-
raphy view. Sensitivity analyses excluding women with very early or late menopause, those
under 40 or over 70 years, and women with self-reported versus measured BMI were also
conducted.
Results
The 11,423 ICMD women ranged in age from 35 to 85 years at mammography, with at least
500 women in each 5-year age category from 35 to 70 (Table 1). Mean age at mammography
was 45.6 (SD 4.9) in premenopausal women and 57.5 years (SD 6.4) in the 59% of women who
were postmenopausal. East Asian women had both the smallest mean BMI and the smallest
mean breast area for BMI (
p
breast area 0.2 to 1.2 cm smaller than ICMD average) (S2 Fig),
and black women had the largest mean breast area for BMI (
p
breast area 0.5 to 1.3 cm larger
than ICMD average). Crude trends for PD and dense area with age were inverse, held across
most population groups, and appeared steeper around age 50 years than at either extreme of
the age range studied (Figs 1 and S3).
Menopause
Menopausal differences showed no or low inconsistency across population groups for PD
(I2 = 16.5%) and dense (I2 = 26.5%), non-dense (I2 = 0%), and breast area (I2 = 0%) (Figs 2A,
S4A, S5A and S6A). The combined effect estimates for the menopausal difference showed
lower PD and smaller dense area in postmenopausal compared to premenopausal women of
the same age, but larger non-dense area and slightly larger breast area. These differences did
not differ by ASR category (Fig 2A; p = 0.31 for PD). The findings from the pooled analyses
closely matched the meta-analytic results, but confidence intervals (CIs) were narrower
(Tables 2 and S2): the
p
PD difference was −0.46 cm (95% CI: −0.53, −0.39), which was driven
by a smaller
p
dense area (difference −0.55 cm [95% CI: −0.65, −0.45]) and larger
p
non-dense
area (difference +0.32 cm [95% CI: 0.21, 0.43]). However, in contrast to the meta-analysis
combined estimate, breast area was not significantly larger in postmenopausal compared to
premenopausal women (0.04 cm [95% CI: −0.07, 0.14]) (S2 Table).
International study of mammographic density and ageing
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The menopause-associated PD difference held across the subgroups of women examined.
Where effect modification was present, the associations differed in magnitude, but not direc-
tion (Tables 2 and S2). For PD and dense area, interactions were found with parity, age at first
birth, HRT use, BMI, and breast area for BMI (e.g., tests for interaction with PD, p = 0.11, 0.04,
0.08, 0.005, and 0.06, respectively; Table 2), and were independent of each other. The magni-
tude of the menopause-associated difference in dense area, and consequently in PD, was larger
in women with lower breast cancer risk profiles, i.e., larger in women who had had an early
Table 1. Characteristics of ICMD participants by age: Menopausal status, BMI, and measures of mammographic density.
Characteristic Age at mammography (years)
35–39 40–44 45–49 50–54 55–59 60–64 65–69 70 All
Number of women, by broad ethnic group
(ordered by decreasing breast area for BMI)*
All 502 1,639 2,045 2,884 1,984 1,451 722 196 11,423
Black 67 139 159 251 176 136 34 29 991
Eastern Mediterranean 89 423 408 516 244 193 140 49 2,062
White 74 476 896 1288 844 647 345 69 4,639
South Asian and Malay 17 135 155 286 310 219 52 7 1,181
Mestizo and Hawaiian 121 134 102 122 51 30 23 1 584
East Asian 119 324 304 400 347 216 129 32 1,871
Woman characteristics: mean (SD) unless stated
otherwise
Age at mammography (years) 37.7
(1.4)
42.1
(1.5)
47.3
(1.5)
52.1
(1.5)
57.1
(1.5)
62.1
(1.4)
66.8
(1.4)
73.2
(3.6)
52.6
(8.2)
Percent postmenopausal† 3.2 5.9 18.5 66.9 96.5 99.7 99.6 99.0 58.6
Age at menopause (years) 39.8
(9.9)
41.7
(7.5)
44.2
(5.4)
47.3
(4.9)
49.0
(5.1)
49.1
(5.3)
49.1
(5.4)
47.8
(5.2)
48.1
(5.5)
Parity 2.2 (1.3) 2.3 (1.4) 2.3 (1.6) 2.5 (1.7) 2.8 (1.8) 3.2 (2.1) 3.4 (2.4) 3.4 (2.6) 2.6 (1.8)
Age at first birth, parous women 24.3
(4.9)
25.2
(5.4)
24.9
(5.3)
24.1
(5.1)
24.0
(5.1)
23.6
(4.8)
23.8
(4.9)
24.1
(5.6)
24.3
(5.2)
Percent HRT ever use 5.4 9.3 13.1 25.4 32.6 34.7 44.0 39.8 24.3
BMI‡ (kg/m2) 25.5
(5.4)
26.2
(5.3)
26.8
(5.8)
27.3
(5.5)
27.2
(5.2)
27.2
(5.4)
27.5
(5.6)
26.7
(5.8)
26.9
(5.5)
Mammographic measures: mean (SD)
Percent density (%) 29.9
(15.4)
27.9
(15.0)
27.4
(15.0)
22.5
(13.8)
18.7
(12.3)
16.9
(11.8)
16.3
(12.3)
17.9
(14.9)
22.6
(14.4)
Dense area (cm2) 37.7
(20.9)
37.2
(21.3)
36.2
(21.6)
31.8
(21.2)
27.0
(18.6)
25.0
(17.6)
24.2
(18.7)
26.5
(18.4)
31.3
(20.8)
Breast area (cm2) 141.9
(68.8)
149.6
(71.3)
148.9
(72.1)
156.9
(70.7)
159.2
(65.3)
164.7
(71)
168.2
(72.7)
177.5
(77.3)
156.3
(70.7)
Non-dense area (cm2) 104.3
(65.1)
112.5
(67.6)
112.6
(68.0)
125.2
(67.5)
132.3
(64.2)
139.8
(69.1)
144.0
(70.7)
151.0
(76.8)
125.0
(68.5)
Breast area for BMI‡ (cm) 0.13
(1.82)
0.12
(1.96)
−0.10
(1.88)
−0.05
(1.94)
−0.01
(1.86)
0.06
(2.01)
0.00
(1.98)
0.51
(2.02)
0.00
(1.93)
*Ethnic groups include women of this ethnicity from the following countries. Black: Kenya, South Africa, US, UK. Eastern Mediterranean: Egypt, Iran, Israel
(Arab), Israel (Jewish), Turkey. White: Australia (Australian, Greek, and Italian), Canada, Netherlands, Norway, Poland, Spain, UK, US. South Asian and
Malay: India, Malaysia (Indian), Malaysia (Malay), Singapore (Indian), Singapore (Malay), UK. Mestizo and Hawaiian: Chile, Mexico, Hawaii. East Asian:
Hong Kong, Japan, US (Japanese), Korea, Malaysia (Chinese), Singapore (Chinese).
†At the time of mammography.
‡Difference in square-root breast area adjusted for BMI compared to ICMD average.
BMI, body mass index; HRT, hormone replacement therapy; ICMD, International Consortium on Mammographic Density; SD, standard deviation.
https://doi.org/10.1371/journal.pmed.1002335.t001
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age at first birth (difference in
p
dense area of −0.84 cm if <20 years and −0.30 cm if30
years at first birth; Table 2), in women with higher parity, and in never and past HRT users
(and null in current users). Across the broad ethnic groups, menopause–MD associations
were of a similar magnitude, except for a larger decline in
p
PD (−0.75 cm [95% CI: −0.93,
−0.57]) in the South Asian and Malay group. For effect modification by BMI, in contrast to
the aforementioned interactions, whose effects on PD and dense area were in similar direc-
tions, the largest menopause-associated differences in dense area occurred in women with a
BMI 30 kg/m2, whilst these women tended to have the smallest menopause-associated dif-
ferences in PD (Table 2). Amongst women with a BMI 35 kg/m2, postmenopausal women
had smaller breast areas than premenopausal women, in contrast to findings of no difference
in other categories (S2 Table).
Age
Meta-analyses (Fig 2B and 2C) and pooled analyses (Table 3) showed very similar age–MD
associations. For a 10-year increase in age, the difference in
p
PD was −0.24 cm among pre-
menopausal women and −0.38 cm among postmenopausal women (p for interaction by meno-
pausal status = 0.15). These associations reflect similar inverse
p
dense area–age associations
(−0.27 and −0.32 cm for pre- and postmenopausal women). However, whereas in premeno-
pausal women PD differences occurred without a difference in breast area, in postmenopausal
women
p
breast area was 0.34 cm (95% CI: 0.24, 0.39) larger per 10-year age increase (S3 and
S4 Tables; S5B and S5C Fig). PD–age associations had low inconsistency across population
groups (I2 ~ 30%) and across ASR categories; in postmenopausal women, all point estimates
were negative.
Fig 3 shows overall and group-specific fitted associations of MD measures with age, includ-
ing a main effect of menopausal status and a menopause-by-age interaction term to allow for
Fig 1. Polynomial smoothed curves of the crude association of percent mammographic density with age, for each population group within
broad ethnic groups. The broad ethnic groups are organised from largest (black women) to smallest (East Asian women) average breast area for BMI.
Full names and details of studies/population groups presented in this figure are provided in S1 Text). Adjustments: none. PD, percent mammographic
density.
https://doi.org/10.1371/journal.pmed.1002335.g001
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different age associations (slopes) in pre- and postmenopausal women. Predictions were made
by age, assuming premenopausal up to age 50 years and postmenopausal thereafter; thus, the
change at age 50 years represents menopausal difference. In contrast to the multiple effect
modifiers found for the PD–menopause difference, MD–age associations did not differ sub-
stantially between women grouped by most reproductive factors (S3 and S4 Tables; Fig 3). In
Fig 3 the few exceptions include a smaller age-associated PD difference in current and ever
users of HRT compared to never users (p for interaction = 0.045; S4 Table), which appeared to
be driven by a differential association with dense area (p = 0.007) and not with non-dense or
breast area (p = 0.46 and 0.23, respectively). Additionally, among premenopausal women,
there was some evidence that the inverse
p
dense area–age association was stronger in nullipa-
rous than parous women (−0.68 versus −0.25 overall, p for interaction = 0.06), and whilst there
were no differences by ethnicity in premenopausal women, in postmenopausal women the
PD–age slope was shallowest for black women (Fig 3).
Further examination of MD–age associations using the best-fitting flexible fractional poly-
nomials revealed that such non-linear models were not a better fit than the simplest linear
Fig 2. Association of square-root percent mammographic density with menopausal status and age. Associations of square-root percent
density, by population group, with (a) menopausal status, (b) age among premenopausal women, and (c) age among postmenopausal women, meta-
analysed overall and by ASR in source population (low, medium, high). Associations are adjusted for age (for [a] only), BMI, BMI2, parity, age at first
birth, HRT use (never, current, former, ever, unknown), mammography view, and MD reader. Full names and details of studies/population groups
presented in this figure are provided in S1 Text. Chile is excluded from (a) and (c) as all women were premenopausal. Norway, Australia (Greek), and
Australia (Italian) were not included in (a) and (b) as all women were postmenopausal. Turkey was excluded from (a) as selection of women implied
that age completely determined menopausal status. ASR, age-standardised incidence rate; BMI, body mass index; CI, confidence interval; HRT,
hormone replacement therapy; MD, mammographic density; PD, percent mammographic density.
https://doi.org/10.1371/journal.pmed.1002335.g002
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Table 2. Difference in square-root mammographic density measures in postmenopausal compared to premenopausal women and by time since
menopause: Overall and in subgroups (pooled analyses).
Variable Number of women Post- versus premenopausal difference*
Percent density Dense area
Premenopausal Postmenopausal Difference (dense width
[cm] in 10 × 10 cm square)
95% CI or
p-value
Difference (dense
square width [cm])
95% CI or
p-value
All women −0.46 −0.53,
−0.39
−0.55 −0.65,
−0.45
Parity
Nulliparous 507 612 −0.30 −0.46,
−0.14
−0.43 −0.64,
−0.22
Parity 1–2 2,292 2,564 −0.46 −0.55,
−0.37
−0.49 −0.61,
−0.37
Parity 3–4 1,439 2,349 −0.50 −0.61,
−0.40
−0.63 −0.76,
−0.49
Parity 5 296 956 −0.53 −0.71,
−0.35
−0.75 −0.99,
−0.51
p-interaction 0.11 0.06
Age at first birth (years)†
<20 612 1,231 −0.63 −0.77,
−0.49
−0.84 −1.02,
−0.65
20to <25 1,307 2,313 −0.47 −0.57,
−0.36
−0.57 −0.71,
−0.43
25to <30 1,382 1,658 −0.51 −0.62,
−0.40
−0.55 −0.70,
−0.41
30 730 669 −0.36 −0.51,
−0.22
−0.30 −0.50,
−0.11
p-interaction 0.04 <0.001
HRT‡
Never 3,223 3,654 −0.49 −0.57,
−0.41
−0.56 −0.67,
−0.45
Past 137 673 −0.50 −0.74,
−0.26
−0.69 −0.88,
−0.50
Current 120 825 −0.11 −0.37, 0.14 −0.18 −0.51, 0.16
Ever 26 436 −0.29 −0.81, 0.23 −0.18 −0.86, 0.50
Missing 1,028 893 −0.46 −0.60,
−0.32
−0.69 −0.88,
−0.50
p-interaction 0.08 0.07
BMI (kg/m2)
<20 305 362 −0.58 −0.79,
−0.38
−0.35 −0.62,
−0.07
20 to <25 1,816 2,223 −0.54 −0.64,
−0.44
−0.47 −0.60,
−0.34
25 to <30 1,355 2,200 −0.41 −0.52,
−0.31
−0.54 −0.67,
−0.40
30 to <35 702 1,114 −0.48 −0.61,
−0.35
−0.76 −0.93,
−0.59
35 356 582 −0.21 −0.38,
−0.03
−0.62 −0.85,
−0.39
p-interaction 0.005 0.02
Breast area for BMI
quintiles
1 898 1,288 −0.37 −0.49,
−0.25
−0.26 −0.41,
−0.10
2 939 1,281 −0.42 −0.54,
−0.30
−0.39 −0.55,
−0.24
(Continued )
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models for PD (p = 0.42), dense area (p = 0.90), and breast area (p = 0.09) in premenopausal
women and for all 4 MD measures in postmenopausal women (p = 0.23, 0.66, 0.53, and 0.91
for PD, dense, non-dense, and total breast area, respectively), thus suggesting that there is no
plateauing of MD within this age range. For non-dense area in premenopausal women, a
Table 2. (Continued)
Variable Number of women Post- versus premenopausal difference*
Percent density Dense area
Premenopausal Postmenopausal Difference (dense width
[cm] in 10 × 10 cm square)
95% CI or
p-value
Difference (dense
square width [cm])
95% CI or
p-value
3 935 1,256 −0.45 −0.57,
−0.33
−0.53 −0.69,
−0.38
4 872 1,311 −0.46 −0.58,
−0.34
−0.67 −0.83,
−0.52
5 871 1,316 −0.59 −0.72,
−0.47
−1.00 −1.16,
−0.85
p-interaction 0.06 <0.001
Ethnic group
Black 342 628 −0.30 −0.48,
−0.12
−0.60 −0.88,
−0.32
Eastern Mediterranean 937 944 −0.46 −0.59,
−0.32
−0.63 −0.84,
−0.42
White 1,774 2,777 −0.43 −0.53,
−0.33
−0.43 −0.56,
−0.30
South Asian and Malay 327 834 −0.75 −0.93,
−0.57
−0.72 −0.99,
−0.44
Mestizo and Hawaiian 297 179 −0.46 −0.77,
−0.15
−0.39 −0.77,
−0.01
East Asian 810 1,041 −0.48 −0.62,
−0.34
−0.39 −0.58,
−0.20
p-interaction 0.01 0.15
Years since menopause**
0–1.9 — 548 0 0
2–4.9 — 1,133 −0.05 −0.18, 0.08 −0.07 −0.24, 0.11
5–9.9 — 1,664 −0.24 −0.37,
−0.11
−0.27 −0.44,
−0.10
10–14.9 — 1,295 −0.30 −0.44,
−0.16
−0.36 −0.54,
−0.17
15 — 1,375 −0.29 −0.45,
−0.14
−0.37 −0.57,
−0.17
p-difference <0.001 <0.001
Trend in years since
menopause, per 10 years
6,015 −0.10 −0.17,
−0.04
−0.13 −0.22,
−0.05
Estimated from a multi-level model on pooled data, with level 3 = population group, level 2 = woman, and level 1 = MD reading. All models are adjusted for
age, BMI, BMI2, mammogram view, image type, reader, parity, age at first birth, and HRT use.
*Difference in square-root MD (postmenopausal minus premenopausal) in each subgroup was generated from menopause-by-subgroup interaction term.
†Parous women only.
‡HRT categories reflect the different levels of HRT use details available for different studies; women do not appear in more than 1 category.
**Postmenopausal women only, age-adjusted. N = number of women with percent density measurement (N for other measures is −0.4% to +1.3%
different).
BMI, body mass index; CI, confidence interval; HRT, hormone replacement therapy; MD, mammographic density.
https://doi.org/10.1371/journal.pmed.1002335.t002
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fractional polynomial model had a better fit than a linear model (p = 0.008), as the positive
association with age was not seen until around age 45 years. In sensitivity analyses, the PD–age
association in premenopausal women was attenuated from −0.24 to −0.18 if older premeno-
pausal women (>50 years) were excluded, and postmenopausal PD–age associations were
stronger (increased from −0.38 to −0.47) when women over age 65 years were excluded (esti-
mates are provided here and do not appear in tables).
Table 3. Difference in square-root mammographic density measures with a 10-year difference in age, in pre- and postmenopausal women.
Variable Premenopausal women Postmenopausal women
N Percent density (width
[cm] of dense square in
a 10 × 10 cm square
area)
Dense area (width [cm]
of dense square)
N Percent density (width
[cm] of dense square in
a 10 × 10 cm square
area)
Dense area (width [cm]
of dense square)
Difference 95% CI or p-
value
Difference 95% CI or p-
value
Difference 95% CI or p-
value
Difference 95% CI or p-
value
Age, per 10 years 4,534 −0.24 −0.34,
−0.14
−0.27 −0.41,
−0.14
6,481 −0.38 −0.44,−0.33 −0.32 −0.39,
−0.24
p-interaction by menopausal status 0.15 0.67
Age category (years) 4,456 6,466
35 to <40 464 0.09 −0.05, 0.22 0.10 −0.09, 0.28 — — — — —
40 to <45 1,478 0 — 0 — 96 0.38 0.10, 0.66 0.33 −0.04, 0.70
45 to <50 1,591 −0.07 −0.17, 0.02 −0.15 −0.28,
−0.02
365 0.13 −0.02, 0.28 0.00 −0.20, 0.19
50 to <55 923 −0.23 −0.36,
−0.10
−0.28 −0.46,
−0.11
1,857 0 — 0 —
55 to <60 — — — — — 1,867 −0.24 −0.33,
−0.16
−0.21 −0.32,
−0.11
60 to <65 — — — — — 1,407 −0.46 −0.55,
−0.37
−0.41 −0.53,
−0.29
65 to <70 — — — — — 692 −0.58 −0.70,
−0.46
−0.53 −0.68,
−0.37
70 — — — — — 182 −0.67 −0.88,
−0.46
−0.57 −0.85,
−0.29
p-difference <0.001 0.002 <0.001 <0.001
Difference per 10-year increase in
age by broad ethnic group*
Black 342 −0.08 −0.37, 0.22 −0.23 −0.63, 0.16 628 −0.17 −0.31,
−0.02
−0.19 −0.33,
−0.06
Eastern Mediterranean 937 −0.20 −0.45, 0.04 −0.31 −0.64, 0.02 944 −0.32 −0.47,
−0.18
−0.42 −0.53,
−0.31
White 1,774 −0.36 −0.53,
−0.18
−0.36 −0.59,
−0.13
2,777 −0.42 −0.51,
−0.34
−0.32 −0.40,
−0.24
South Asian and Malay 327 −0.27 −0.61, 0.06 −0.31 −0.75, 0.12 834 −0.49 −0.65,
−0.32
−0.49 −0.64,
−0.33
Mestizo and Hawaiian 297 −0.01 −0.34, 0.32 −0.16 −0.58, 0.25 179 −0.55 −0.86,
−0.25
−0.25 −0.47,
−0.03
East Asian 810 −0.22 −0.41,
−0.02
−0.16 −0.42, 0.11 1,041 −0.38 −0.52,
−0.25
−0.22 −0.33,
−0.11
p-interaction 0.43 0.90 0.02 0.34
Estimated from a multi-level model of pooled data, with level 3 = population-group, level 2 = woman, and level 1 = MD reading. All models are adjusted for
BMI, BMI2, mammogram view, image type, reader, parity, age at first birth, and HRT use.
*Age-associated differences in each subgroup were generated from age-by-subgroup interaction terms. N = number of women with percent density
measurement (N for other measures differs by −0.5% to +1.8%).
BMI, body mass index; CI, confidence interval; HRT, hormone replacement therapy; MD, mammographic density.
https://doi.org/10.1371/journal.pmed.1002335.t003
International study of mammographic density and ageing
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002335 June 30, 2017 12 / 20
Fig 3. Modelled associations of square-root percent density, dense area, and total breast area with age and menopausal status, overall
and by subgroups. Square-root dense/breast area is the width of a square representing the dense/breast area; square-root PD is the width of a
dense-area square within a 10 cm × 10 cm square. All models are adjusted for age, BMI, BMI2, parity, age at first birth, HRT use (never, ever, past,
current, not known), MD reader, image type, and mammography view. BMI, body mass index; CI, confidence interval; ICMD, International
Consortium on Mammographic Density;HRT, hormone replacement therapy; MD, mammographic density.
https://doi.org/10.1371/journal.pmed.1002335.g003
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Ageing and the menopause
In postmenopausal women, there is sufficient variability in age at menopause (IQR 45 to 52
years) to analyse the impact of age-adjusted years since menopause, which was independently
associated with
p
PD (−0.10 per 10 years [95% CI: −0.17, −0.04]), an effect that was present up
to 15 years after menopause (Table 2). After adjusting for years since menopause, the PD–age
association reduced from −0.38 to −0.29 per 10 years, but remained significant.
Discussion
Main findings
Across diverse populations of breast-cancer-free women worldwide, we assessed how MD is
related to age and menopausal status. Overall, despite inevitable differences between contribut-
ing studies, we found consistency in the direction of associations of age and menopausal status
with PD and its component tissues across ICMD women. Assuming that inferences from these
cross-sectional data reflect within-woman changes, the greatest reduction in MD occurred
upon menopausal transition, when dense area declined from a mean of 16.0 to 12.5 cm2,
equivalent to 15 to 20 years of ageing. This difference in PD between post- and premenopausal
women of the same age was present up to 15 years after the menopause and may be greater in
women with lower breast cancer risk profiles (early age at first birth, high parity). PD also
decreased with increasing age both among premenopausal and postmenopausal women. In
premenopausal women, these declines were entirely due to breast compositional changes, i.e.,
due to a decline in dense area and an equal but opposite increase in non-dense area. However,
in postmenopausal women, PD reductions were also accompanied by increasing breast area
and continued beyond 70 years of age.
Comparison to other studies
The large decrease in MD at menopause after adjusting for age is largely consistent with previ-
ous observations in westernised countries, either from within-woman or between-woman
comparisons [2,8–10,12,15]. Boyd et al. [2] examined differences in breast area before and
after menopause and found no significant change, indicating that lower PD after menopause
may be due a compositional change alone. Only 1 longitudinal study reported a decline in PD
at menopause that was non-significant, although in this study the largest age-related decline
did occur around the age of menopause (between ages 45 and 55 years) [11].
Comparisons of age-related changes have been more variable. In ICMD, we found no
strong evidence of different PD–age or dense area–age slopes in pre- and postmenopausal
women, in agreement with the full longitudinal data from 1 of the ICMD studies, the Mel-
bourne Collaborative Cohort Study/Australian Breast Cancer Family Registry [22], but
differing from studies that reported steeper MD declines in either premenopausal [14] or post-
menopausal women [9,11]. In addition, there was no strong evidence of non-linear MD–age
trends in ICMD, but 3 longitudinal studies have found that PD (and dense area, where exam-
ined) declines most rapidly around ages 45 to 55 or 60 years [8,11,12], including the Mel-
bourne study, which also observed a possible plateau after 65 years of age [11,12,22].
Biological plausibility
The remarkable consistency of the age and menopausal effects on MD across diverse female
populations spanning all continents suggests that these associations reflect a biological process
common to all women. The extent of the decline in MD may be modified by ‘external’ factors,
such as reproductive or other lifestyle or environmental factors. These observations lend
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credibility to the hypothesis that the sharp decline in MD over the menopause is a phenotypic
marker of the decline in the rate of breast tissue ageing [4], which results in Clemmesen’s
hook in the age–breast cancer incidence curves across the world. However, this simple parallel
ignores the well-established molecular and aetiological heterogeneity of breast cancer [5]. Nota-
bly, although it has previously been hypothesized that the hormonal drivers of PD would result
in it being a stronger risk marker for oestrogen receptor (ER)–positive than ER-negative breast
cancer, a large differential in the MD-breast cancer association by tumour subtype does not
appear to be present [23]. This finding should perhaps not be surprising, if the menopausal
decline in PD, observed universally here, is related to the incidence curves of breast cancer with
age, which feature a much stronger menopausal decline in the age-acceleration of incidence
rates for ER-negative tumours than for ER-positive tumours [5,24]. At the tissue level, changes
involving the dense area arise from changes in stromal tissue and/or in epithelial tissue, whilst
changes in PD are additionally affected by changes in adipose tissue in the breast. Declining
dense area likely reflects involution of terminal duct lobular units. X-rays of histological tissue
show that these units have raised concentrations of radiologically dense areas and that these
areas also decline with age [25]. Two additional observations link MD, terminal duct lobular
units, and breast cancer risk: breast carcinoma arises within epithelial tissue and the radiologi-
cally dense tissue seen on a mammogram [26], and, within cohorts with benign breast disease,
greater terminal duct lobular unit involution is predictive of subsequent breast cancer risk [27].
At a systemic level, a hormonal pathway is most certainly implicated in MD changes that
occur during the menopausal transition. Several reproductive hormones decline at different
stages of the transition [28], some of which may contribute to the MD decline. Combined
exogenous oestrogen and progesterone are known to increase PD [29], whilst in premeno-
pausal women, endogenous oestrogen levels are positively associated with PD [30]. The shal-
lower age-related declines in PD in premenopausal women compared to postmenopausal
women in our study may reflect similar hormonal pathways. Further, in postmenopausal
women only, an increase in breast area also contributed to the decreasing PD. This is likely to
reflect a true increase in breast volume as breast area and thickness were positively correlated
in ICMD (r = 0.18).
Strengths and limitations
The present study is greatly enhanced by the heterogeneity of the study populations included
in ICMD, in terms of a wide range of BMI values, reproductive characteristics, ages (40-year
age range), and ethnicities and their associated range of breast sizes and composition, making
this, to our knowledge, the largest multi-ethnic, multi-country study of MD to date. The con-
sistent findings are likely to reflect intrinsic biological processes and should therefore apply
to the general population of women worldwide. Our separate analyses of tissue components
revealed important differences in the drivers of changes in breast tissue composition at differ-
ent life stages. However, inherent to the consortial nature of ICMD is the fact that we relied on
existing data; thus, some sample sizes were smaller, not all studies included women spanning
the full age range, and there is variability in image types and exposure variable definitions.
Menopause was included as binary variable due to the limitations of the data, but may occur
over many months or years. The definition of menopausal status also varied, from simple self-
reports to complex algorithms, measured at or some time before or after mammography.
Potential misclassification bias might attenuate the estimate of the menopausal effect but is
unlikely to affect within-population group estimates of the menopause difference. Addition-
ally, including some perimenopausal women would also underestimate a menopausal effect.
In the 31% of women with self-reported anthropometry, possible underreporting of weight
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and overestimation of height, particularly in older women, would lead to an underestimation
of BMI [31]; thus, part of the increase of breast area postmenopausally may be due to incom-
plete adjustment for BMI. In addition, the validity of BMI as a measure of total body adiposity
across such diverse populations is uncertain.
Women in ICMD were recruited from a range of settings, including some that were not
population-based screening; thus, there is likely an overrepresentation of symptomatic or
high-risk women. Nevertheless, the present findings rely on the representativeness of the asso-
ciations and not of the sample populations; thus, any lack of representativeness of study popu-
lations would affect results only if there was an age-related pattern to representativeness. In a
similar manner, cross-sectional associations may only partially reflect within-woman changes,
as birth cohort effects on MD, through factors unadjusted for, may confound associations.
These findings should be verified with longitudinal data in which within-woman changes can
be examined.
Implications
There are broader implications of the profile of MD with ageing. Similar to the reduced sen-
sitivity of mammography in younger women than in older women in organised screening
programs [32], because of the former group’s higher average breast density, this problem is
also likely to affect the performance of mammography as part of the diagnostic work-up of
symptomatic breast cancers. Low- and middle-income countries may be disproportionately
affected by this issue, because of the young population structures and thus younger average
age at breast cancer diagnosis. Further, if MD reflects the rate of breast tissue ageing, the par-
allel to Pike’s model suggests that cumulative MD to a given age is the pertinent marker of
breast cancer risk. Indeed, cumulative density has been shown to be highly correlated with
age-related breast cancer risk [11], and women whose MD decreases substantially over
time may be at lower risk of breast cancer than those who maintain the same density [10,33].
More efficient and cost-effective stratified approaches to population-based breast cancer
screening using MD-based risk scores have been suggested [34]. Placing a woman in a partic-
ular MD-based risk stratum would be aided by the fact that MD displays a high level of track-
ing within a woman over time, at least postmenopausally [12], but it is not known whether
risk predictions might be improved if earlier life periods, before MD tracking is established,
were included.
Finally, based on the current findings that MD is in general highest earlier in life, primary
prevention efforts might best be targeted to younger ages, reducing breast density earlier in
life, leading to a lower cumulative MD across life. Studies of breast density in girls or younger
women that use MRI or dual-energy X-ray absorptiometry (DXA) imaging are fewer. They
have found suggestions of increased breast density associated with greater birth size [35], dura-
tion of use of hormonal contraceptives [36], higher testosterone levels [37], and lower child-
hood BMI, independent of current BMI [38]. At adult ages, the potential actions needed to
lower breast density for a reduction in breast cancer risk, apart from the known pregnancy-
associated effects, include lowering alcohol intake [39], whilst the protective effect of physical
activity does not appear to be mediated through MD [40]. Further, in high-risk women and in
women with ductal carcinoma in situ, tamoxifen reduces breast cancer risk through a reduc-
tion in MD [41]. Given the relatively low uptake of such oral chemoprevention therapies,
other risk-lowering options for women with high breast cancer risk and raised MD may come
from the ongoing trials of oral low dose and topical tamoxifen [42]. The consistency of the
MD–ageing associations internationally is suggestive of an intrinsic shared biology, which
might also extend to other modifiable determinants of MD.
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